Neurodegenerative Disorders Clinical Trial
Official title:
A Registered Observational Cohort Study on Color Discrimination Deficit Associated With Neurodegenerative Disorders.
Color discrimination deficit is a common manifestation of Alzheimer's disease (AD). However, the pathophysiology of this dysfunction remains poorly understood. The aim of the present study was to evaluate color discrimination using the Farnsworth-Munsell 100 hue test in patients with AD and mild cognitive impairment (MCI), compared with age-matched control subjects. As a secondary aim, we evaluated whether the outcomes of these visual tests were associated with cognitive.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT02823158 -
Bilateral Pallidal Stimulation in Patients With Advanced Parkinson's Disease-LATESTIM
|
N/A | |
| Recruiting |
NCT04926259 -
Tau PET Imaging With 18F-T807(AV1451) in Neurodegenerative Disorders
|
Early Phase 1 | |
| Withdrawn |
NCT02086240 -
Reproducibility of the 11C-PBR28 PET Signal
|
N/A | |
| Active, not recruiting |
NCT01589809 -
Effect of Nicotinamide in Friedreich's Ataxia
|
Phase 2 | |
| Recruiting |
NCT05394974 -
Joint Consultation Between a Neurologist and a Clinical Psychologist
|
||
| Recruiting |
NCT04684602 -
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
|
Phase 1/Phase 2 | |
| Completed |
NCT02860338 -
COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE
|
N/A | |
| Recruiting |
NCT00149175 -
Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment
|
Phase 1 | |
| Active, not recruiting |
NCT00874783 -
Development of iPS From Donated Somatic Cells of Patients With Neurological Diseases
|